but inhibited the response to melatonin. In contrast to its effect on CAMP accumulation, melatonin had no effect on dopamine-stimulated inositol phosphate accumulation.
These results suggest that melatonin receptors are coupled to dopamine receptor-regulated adenylate cyclase via an inhibitory G protein, and demonstrate another mechanism, in addition to inhibition of dopamine release, through which melatonin can modulate dopaminergic neurotransmission.
[Key words: melatonin receptors, Dl dopamine receptors, CAMP, inositol phosphates, pertussis toxin, retina, receptor cross talk] Melatonin and dopamine are putative neuromodulators with opposing roles in retinal physiology (Besharse et al., 1988) . Melatonin is synthesized in and released from photoreceptor cells (e.g., Redburn and Mitchell, 1989; Iuvone et al., 1990; Cahill and Besharse, 1992; Zawilska and Iuvone, 1992; Thomas et al., 1993; Wiechmann and Craft, 1993) , and dopamine is synthesized in amacrine and interplexiform cells (reviewed in Ehinger, 1977; Iuvone, 1986) . In retina, melatonin activates rod photoreceptor disk shedding (Besharse and Dunis, 1983; Besharse et al., 1984) and promotes dark-adaptive retinomotor movements (Cheze and Ali, 1976; Pang and Yew, 1979; Pierce and Besharse, 1985) . In contrast, dopamine inhibits rod photoreceptor disk shedding (Pierce and Besharse, 1986; Besharse et al., 1988) and promotes light-adaptive retinomotor movements (Pierce and Besharse, 198.5; Dearry and Burnside, 1986) . Melatonin inhibits electrically stimulated and light-evoked release of ACh (Mitchell and Redburn, 1991) , while dopamine stimulates ACh release (Hensler and Dubocovich, 1986) . Melatonin enhances the sensitivity of horizontal cells (Wiechmann et al., 1988) , and decreases the trans-epithelial potential of retinal pigment epithelial (RPE) cells and the c-wave of the electroretinogram (ERG) (Nao-I et al., 1989; Rudolf et al., 1992) . Dopamine decreases the response of horizontal cells to full-field stimulation (Mange1 and Dowling, 1987) and increases the transepithelial potential of RPE cells and the c-wave amplitude (Gallemore and Steinberg, 1990; Rudolf et al., 1992) . Melatonin is synthesized and released in retina in darkness, and in some species, under the influence of a circadian clock (Hamm and Menaker, 1980; Besharse and Iuvone, 1983; Redburn and Mitchell, 1989) , while dopamine synthesis and release in retina is stimulated by steady or flickering light (Kramer, 1971; Iuvone et al., 1978; Dowling and Watling, 1981; Parkinson and Rando, 1983; Godley and Wurtman, 1988; Boatright et al., 1989) . Melatonin inhibits dopamine synthesis and release (Dubocovich, 1983; Nowak, 1988; Nowak et al., 1992; Boatright et al., 1994) , and melatonin synthesis and release are inhibited by dopamine (Iuvone and Besharse, 1986; Iuvone et al., 1987 Iuvone et al., , 1990 Zawilska and Iuvone, 1989; Cahill and Besharse, 1991) . Thus, melatonin and dopamine appear to form the basis of a neurochemical feedback loop that regulates opposing physiological processes.
High-affinity melatonin receptors have been characterized in retina using 2-1Z51-iodomelatonin as a radioligand (e.g., Dubocovich and Takahashi, 1987; Laitinen and Saavedra, 1990; Wiechmann and Wirsig-Wiechmann, 1991) . Occupation of melatonin receptors in retinal membranes inhibits forskolin-stimulated adenylate cyclase (Niles et al., 1991) . We recently reported that cultured neural cells prepared from chick embryo retina have 2-iodomelatonin binding sites, and that occupation of melatonin receptors in these cultures inhibits forskolin-stimulated CAMP accumulation (Iuvone and Gan, 1994a) . Intact retina and retinal cell cultures are rich in Dl dopamine receptors, activation of which stimulates adenylate cyclase (Brown and Makman, 1972; Watling et al., 1979; DeMello et al., 1982) . In this study, we examined the possible interaction of melatonin receptors and Dl dopamine receptors in cultured retinal cells, and report that these receptors appear to be colocalized on retinal neurons and have opposing effects on CAMP formation.
A preliminary report of some of these results has been published in abstract form (Iuvone and Gan, 1992) .
Materials and Methods
Cell cultures. Neuronal cell cultures were prepared from embryonic chick retina as described by Adler et al. (1984) , with minor modifications . Briefly, eggs of White Leghorn chickens (Callus domesticus) were incubated at 37.5 + 0.5"C in a humidified incubator. Cultures were prepared from embryonic day 8 neural retina. Neural retinas, apparently free of pigment epithelial or other cells, were dissected and dissociated by trypsinization (0.25% trypsin for 20 min at 37°C) and trituration. Cells were seeded into Falcon culture dishes at a density of 4.5 X lo6 cells/60 mm dish. The culture dishes were pretreated with 0.1 mg/ml of polyornithine in 0.15 M sodium borate (pH 8.4), washed sequentially with H,O and medium 199, and incubated with culture medium containing 20% defined fetal bovine serum (Hyclone, Logan, UT) before seeding. Cells were cultured for 6 d in 6 ml of medium 199 suoolemented with 10% fetal bovine serum, linoleic . . acid-bovine serum albumin (110 p,g/ml), 2 mu glutamine, and penicillin G (100 U/ml), at 37°C under an atmosphere of 5-6.5% CO, in air. All measurements were made after 6 d of culture. The following three cell types were found in the cultures: multipolar neurons, photoreceptors, and apparently undifferentiated round cells.
Assay of CAMP formation. The synthesis of 'H-CAMP in cells prelabeled with 'H-adenine was determined by a modification of the method of Shimizu et al. (1969) . Culture medium was removed by aspiration and replaced by 3 ml of balanced salt solution (BSS; in mu: NaCl, 125.4; KCl, 3.6; MgCl,, 1.2; CaCl,, 1.15; NaHCO,, 22.6; Na,HPO,, 0.4; NaH,PO,, 0.1; Na,SO,, 1.2; D-ghCOSe, 10) containing 5 pCi of 2.8JH-adenine (20.7 Ci/mmol). Cells were returned to the incubator for 2'hr, after which the adenine solution was replaced by 2.85 ml of BSS, containing test compounds as indicated. After a 10 min preincubation, 150 pl of aqueous ascorbate (0.1 or 1 mM), with or without dopamine or SKF 82958 was added. All samples were incubated for 20 min. Melatonin and related drugs were present at the indicated concentrations during the 10 min preincubation and 20 min incubation periods. The incubation was terminated by addition of 250 pl of 77% trichloroacetic acid. Culture dishes were scraped with a spatula, and cells and medium were transferred to tubes. The dishes were washed with 0.5 ml of BSS, and the wash was added to the tubes. An aliquot (50 p,l) of 10 mu CAMP was added as carrier. Samples were homogenized with a Tekmar Tissumizer, and centrifuged at 30,000 X g for 15 min. Aliquots (50 pl) of supernatant fraction were taken for determination of total radioactivity. 3H-cAMP was isolated by sequential chromatography on Dowex 5OW-X4 and alumina as described by Minneman et al. (1979) except that the bed dimension of the Dowex 5OW-X4 columns was 0.8 X 3 cm. Columns were calibrated for recovery using external standards of 3H-cAMP, and standards were run with each assay. The data were corrected for recovery and are expressed as percent conversion ('H-CAMP X lOO/total 3H) or as percentage of dopamine-stimulated CAMP accumulation. Dopamine-stimulated cyclic AMP accumulation is defined as the increment of CAMP above basal levels elicited by dopamine (accumulation in the presence of dopamine minus basal accumulation in the absence of added neurotransmitter).
In some experiments, cells were pretreated with 30 rig/ml of pertussis toxin, which was added directly to the culture medium on the fifth day in vitro. After 18 hr the culture medium containing pertussis toxin was removed and replaced with BSS without toxin. Samples were then processed as described above.
The experiments described in this article were conducted over a three year period with cells grown in the presence of four different lots of fetal bovine serum (Hyclone defined serum lots 991, 2034, 2053, 2280) . Absolute values of CAMP accumulation varied with the different serum lots, but the responses to dopamine and melatonin were similar with all lots. In the earlier experiments of this study (see Figs. 1, 3 ; Tables 4, 5), incubations were conducted in the presence of 5 PM ascorbate, with or without dopamine. Under these conditions, 200 PM dopamine was required .to elicit a large CAMP response. Subsequently, we observed that dopamine was more potent in the presence of 50 pM ascorbate, eliciting a maximal response at approximately 10 FM (see Fig. 2 ). All subsequent experiments were conducted with the higher concentration of antioxidant. CAMP responses to high or low concentrations of dopamine were antagonized by dopamine receptor blockers (see Fig. 1 , Table l), and melatonin produced the same response under both of these conditions.
Assay of inositol phosphate accumulation. Cells were prelabeled with 3H-myo-inositol (0.67 l&i/ml) for 4-5 d. Inositol phosphate accumulation was determined by a modification of previously described meth- ods (Berridge et al., 1982; Wilson et al., 1990) . On the sixth day in vitro, culture medium was removed and washed with 3 ml of lithium-BSS (LiBSS): 10 mM LiCl. 115.4 mM NaCl. 3.6 mM KCl. 1.2 mM MgCl;, 1.15 'mrvr CaCl,, 22.6 mM NaHCO,, 0.4 mM Na,HPOi, 0.1 mM NaH,PO,, 1.2 mM Na,SO,, 0.029 mM EDTA; 10 mM o-glucose. LiBSS (2.85 ml) was added to each dish, and cells were preincubated for 10 min. Test compounds or vehicle were subsequently added in a volume of 0.15 ml and samples were incubated for 60 min. The incubation medium was then aspirated, and 0.75 ml of ice-cold methanol added. Cells were scraped from the dishes with a spatula and added to a tube containing 0.66 ml of chloroform. Dishes were washed with 0.66 ml of distilled water, which was added to the cell suspension. Samples were sonicated for 10 set and centrifuged at 10,000 X g for 5 min to separate aqueous and organic phases. 'H-Inositol phosphates were isolated from the aqueous phase by anion exchange chromatography and measured by liquid scintillation counting as described by Wilson et al. (1990) . Aliquots of the organic phase were counted to determine )H-inositol incorporation into lipid. Addition of dopamine markedly stimulated CAMP accumulation in cultured retinal cells (see Table 1 , Fig.  1 ). The effect of dopamine was inhibited by the dopamine receptor antagonists SCH 23390 (Table 1) and haloperidol (Fig.  1) . Melatonin (100 tIM) had no significant effect on basal CAMP accumulation, but inhibited the stimulation elicited by dopamine by approximately 70% (Fig. 1) . The Dl-selective dopamine receptor agonist SKF 82958 (100 FM) also stimulated CAMP accumulation, and its effect was also inhibited by melatonin (Table  2) . Melatonin reduced the maximal CAMP response to dopamine without significantly affecting its potency (Fig. 2) .
The inhibitory effect of melatonin on dopamine-stimulated CAMP accumulation was concentration-dependent, with an estimated EC,, value (concentration producing a half-maximal effect) of 160 PM and a maximal inhibitory effect of 68% (Fig.  3) . The melatonin receptor agonists, 2-iodomelatonin and 6-chloromelatonin, also reduced dopamine-stimulated CAMP ac- (Fig. 3) . The experiments described above were performed in the absence of a cyclic nucleotide phosphodiesterase inhibitor, and the results could be due to either a stimulation of CAMP breakdown or an inhibition of its formation. The effect of melatonin was therefore reexamined in the presence of 3-isobutyl-l-methylxanthine (IBMX), to address this issue. IBMX (0.3 mu) significantly increased basal CAMP accumulation (Table 3) . Melatonin (300 nM) had no effect on the increased accumulation caused by the phosphodiesterase inhibitor. Dopamine markedly stimulated CAMP accumulation in the presence of IBMX, and this stimulation was significantly attenuated by melatonin (Table 3) . Thus, melatonin appears to inhibit the stimulation of cAMPformation caused by dopamine.
Pretreatment of cultures for 18 hr with pertussis toxin (30 ng/ ml) had no effect on dopamine-stimulated CAMP accumulation, but significantly reduced the inhibitory effect of melatonin (Table 4).
Effect of melatonin on inositol phosphate accumulation. Dopamine (200 p,M) produced a small, but statistically significant stimulation of inositol phosphate accumulation (Table 5) , which was inhibited by haloperidol and SCH 23390 (data not shown). Melatonin had no effect on either basal or dopamine-stimulated inositol phosphate accumulation (Table 5) . Carbachol, a muscarinic cholinergic receptor agonist, produced a much larger stimulation of inositol phosphate accumulation than did dopamine (Table 5) ; the effect of carbachol was also unaffected by melatonin.
Discussion
Previous studies have demonstrated that melatonin modulates dopaminergic neurotransmission in retina by inhibiting dopamine release (Dubocovich, 1983; Nowak, 1988; Boatright et al., 1994) . The present results indicate that melatonin may also modulate retinal dopaminergic neurotransmission at a postsynaptic site by inhibiting the CAMP response to Dl dopamine receptor activation. Melatonin, 2-iodomelatonin, and 6-chloromelatonin inhibited dopamine-stimulated CAMP accumulation, a well established response to Dl dopamine receptor activation in retina (Brown and Makman, 1972) . The EC,, values for inhibition of dopamine-stimulated CAMP accumulation by melatonin and related agonists are similar to those for inhibition of chick retinal dopamine release (Dubocovich and Takahashi, 1987) and to the K, values for inhibition of 2-1251-iodomelatonin binding to chick brain slices (Siuciak et al., 1991) and retinal neurons (Iuvone and Gan, unpublished observation) . The EC,, for inhibition of dopamine-stimulated CAMP accumulation by 2-iodomelatonin (35 PM) is virtually identical to the equilibrium dissociation constant (K,) for 2-Y-iodomelatonin binding to chick retinal neurons in culture (42 PM; Iuvone and Gan, 1994a) . Thus, melatonin and its analogs inhibit dopamine-stimulated CAMP accumulation by activating melatonin receptors similar to those described pre- viously using other functional or binding assays. Furthermore, the inhibitory effect of melatonin on dopamine-stimulated CAMP accumulation was blocked by pretreatment with pertussis toxin, which also attenuates the inhibition by melatonin of forskolin-stimulated CAMP accumulation in retinal cells (Iuvone and Gan, 1994 ), brain (Niles et al., 1991) , and pars tuberalis (Morgan et al., 1990) . Thus, we suggest that melatonin stimulates receptors located on neurons that also contain Dl dopamine receptors, and that the melatonin receptors activate a G,-like guanyl nucleotide binding protein that inhibits the effect of G, activation by Dl dopamine receptor stimulation. Dl dopamine receptors in brain have been reported to be coupled to phospholipase C (Undie and Friedman, 1992) , activation of which stimulates inositol phosphate formation and activation of protein kinase C (Nishizuka, 1992) . We recently demonstrated that dopamine stimulates inositol phosphate accumulation in cultured neural retinal cells by activating a receptor with the phar- macological characteristics of a Dl dopamine receptor (Iuvone and Gan, 1994b) . Remarkably, melatonin inhibits the CAMP response to dopamine but not dopamine-stimulated inositol phosphate accumulation. Thus, melatonin receptors may be colocalized with Dl receptors that are coupled to adenylate cyclase, but not with Dl-like receptors that are coupled to phospholipase C. Alternatively, all three receptor-effector complexes may be colocalized, with melatonin receptors capable of inhibiting G,-mediated adenylate cyclase activation, but not the stimulation of phospholipase C by G, or related G proteins. In retina, Dl dopamine receptors coupled to both adenylate cyclase and phospholipase C may be colocalized on horizontal cells. CAMP mediates the effects of dopamine on horizontal cell gap junction permeability and on glutamate-gated cation conductance (Dowling, 1989) , while the effects of dopamine on horizontal cell neurite extension and spinule formation may involve activation of phospholipase C (DOS Santos Rodrigues and Dowling, 1990; Weiler et al., 1991) . These observations suggest a novel mechanism for modulation of dopaminergic neurotransmission, whereby melatonin interferes with some, but not all of the consequences of dopamine receptor activation.
OControl
Melatonin also failed to alter the stimulation of inositol phosphate accumulation in retinal cell cultures in response to activation of muscarinic cholinergic receptors with carbachol. This result is consistent with a preliminary report that melatonin does not inhibit carbachol-stimulated inositol phosphate accumulation in chick brain slices (Fang et al., 1990) . Melatonin also failed to alter AlF,-induced inositol phosphate accumulation in ovine pars tuberalis (Morgan et al., 1991) , suggesting that melatonin receptors are not negatively coupled to G protein-stimulated phospholipase C. Dopamine-melatonin interactions are not unique to retina, but occur in other parts of the CNS as well. Melatonin inhibits hypothalamic dopamine release (Zisapel and Laudon, 1983 ) and reduces the dopamine content of the nenrointermediate lobe of the pituitary gland (Alexiuk and Vriend, 1993) . Dopamine and melatonin may interact to regulate pituitary gonadotropin release (Acufia-Castroviejo et al., 1993) . Furthermore, it has been snggested that interactions of dopamine and melatonin in the nucleus accumbens may play a role in the behavioral response to antidepressant drugs (Durlach-Misteli and Van Ree, 1992) . Based on the present results, we propose the following working hypothesis for modulation of dopaminergic transmission by melatonin (Fig. 4) . Melatonin may inhibit dopamine release at a presynaptic site (Dubocovich, 1983; Boatright et al., 1994) . The effect of melatonin on dopamine release is dependent on GABAergic neurotransmission, as it is completely blocked by GABA receptor antagonists (Boatright et al., 1994) . It is unclear if melatonin acts to increase the synaptic concentration of GABA or to enhance the response to GABA at a postsynaptic site. In addition, melatonin inhibits the stimulation of adenylate cyclase by Dl dopamine receptor activation at a postsynaptic site. We propose that melatonin receptors and cyclase-coupled Dl dopamine receptors are colocalized in the same neurons, but can not exclude the possibility that melatonin acts on other cells, which release a neurotransmitter that modulates dopamine-stimulated adenylate cyclase activity. In contrast, melatonin has no effect on dopamine-stimulated activation of phospholipase C. It is unclear at present if the cyclase-coupled dopamine receptors and the Dl-like receptors linked to phospholipase C are co-localized or exist on different neurons. It is also not known if melatonin modulates responses to D2 dopamine receptor activation. Melatonin maximally inhibits endogenous dopamine re- lease by 50-70%. Thus, in the presence of melatonin, dopaminergic transmission may be modulated by a combination of reduced dopamine release and a selective reduction of some postsynaptic responses to dopamine receptor activation.
We emphasize the hypothetical nature of this model, which is intended to present a framework for the design of additional experiments. The functional interaction of melatonin receptors and Dl dopamine receptors has only been investigated in cell cultures of embryonic retinal neurons. The cell types generating the observed responses are not yet identified. Additionally, it will be important to determine if a similar functional interaction occurs in intact, adult retina. . Hypothetical model for the modulation of dopaminergic neurotransmission by melatonin. Melatonin receptor activation inhibits dopamine release by a mechanism that involves GABAergic neurotransmission (Boatright et al., 1994 (Iuvone and Gan, 1994b) , which converts phosphatidylinositol 4,5 bisphosphate (PZP2) into two second messengers, inositol trisphosphate (1P3) and diacylglycerol (DAG). Melatonin has no effect on this response. Thus, melatonin may modulate dopaminergic transmission by a combination of reducing dopamine release and inhibiting some of the postsynaptic responses to dopamine receptor activation.
